4958 related articles for article (PubMed ID: 300944)
1. [Peripheral blood lymphocytes in melanoma].
Luchenko IM
Vopr Onkol; 1977; 23(2):53-6. PubMed ID: 300944
[TBL] [Abstract][Full Text] [Related]
2. [Variations of B- and T-lymphocytes in the peripheral blood and variations of the stimulability of cyclic nucleotides in the T-lymphocytes of patients suffering from malignant melanoma (author's transl)].
Busse E; Rose H; Lehnert W
Dermatol Monatsschr; 1979 Sep; 165(9):634-41. PubMed ID: 230989
[TBL] [Abstract][Full Text] [Related]
3. Changes in T and B lymphocyte subpopulations before, during and after chemotherapy for malignant melanoma.
Bernengo MG; Lisa F; Meregalli M; Doveil GC
Int J Tissue React; 1984; 6(6):505-11. PubMed ID: 6335712
[TBL] [Abstract][Full Text] [Related]
4. [Evaluation of T- and B-cell immunity of regional lymph nodes in patients with skin melanoma and prognosis of the disease].
Serov AA; Kadagidze ZG
Vopr Onkol; 1983; 29(12):18-20. PubMed ID: 6607569
[TBL] [Abstract][Full Text] [Related]
5. Humoral and cellular immune reactions 'in vitro' against allogeneic and autologous human melanoma cells.
Peter HH; Kalden JR; Seeland P; Diehl V; Eckert G
Clin Exp Immunol; 1975 May; 20(2):193-207. PubMed ID: 765012
[TBL] [Abstract][Full Text] [Related]
6. In vitro lymphocyte reactivity and T cell levels in patients with melanoma: correlations with clinical and pathological stage.
Silverman NA; Alexander JC; Potvin C; Chretien PB
Surgery; 1976 Mar; 79(3):332-9. PubMed ID: 1083075
[TBL] [Abstract][Full Text] [Related]
7. [Peripheral blood lymphocytes in melanoma].
Luchenko IM
Vopr Onkol; 1978; 24(12):8-14. PubMed ID: 366898
[No Abstract] [Full Text] [Related]
8. [Immune profile in melanoma patients. I. PHA--stimulation of circulating lymphocytes and number of T- and B-lymphocytes (author's transl)].
Knopf B; Wätzig V; Knöll B
Arch Geschwulstforsch; 1978; 48(6):559-64. PubMed ID: 310289
[TBL] [Abstract][Full Text] [Related]
9. Peripheral burst of tumor-specific cytotoxic T lymphocytes and infiltration of metastatic lesions by memory CD8+ T cells in melanoma patients receiving interleukin 12.
Mortarini R; Borri A; Tragni G; Bersani I; Vegetti C; Bajetta E; Pilotti S; Cerundolo V; Anichini A
Cancer Res; 2000 Jul; 60(13):3559-68. PubMed ID: 10910069
[TBL] [Abstract][Full Text] [Related]
10. [T-lymphocytes in the peripheral blood. Study on 113 patients with malignant melanoma].
Klein R; Krüger GR; Sesterhenn K
Z Hautkr; 1978 Feb; 53(3):62-6. PubMed ID: 305173
[TBL] [Abstract][Full Text] [Related]
11. The in vitro effect of a calf thymus extract on the peripheral blood lymphocytes of sixty-six melanoma patients.
Bernengo MG; Capella G; de Matteis A; Tovo PA; Zina G
Clin Exp Immunol; 1979 May; 36(2):279-84. PubMed ID: 314368
[TBL] [Abstract][Full Text] [Related]
12. T and B lymphocytes in malignant melanoma patients.
Babusiková O; Novotná L; Schneková K; Turková D; Havránková M
Neoplasma; 1976; 23(6):635-44. PubMed ID: 1087378
[TBL] [Abstract][Full Text] [Related]
13. [Leukocyte migration inhibition reaction in melanoma].
Kovaleva VL
Vopr Onkol; 1978; 24(1):38-42. PubMed ID: 636368
[TBL] [Abstract][Full Text] [Related]
14. T-cell subsets in melanoma patients evaluated by anti-T-cell monoclonal antibodies.
Bernengo MG; Lisa F; Puiatti P; Meregalli M; Berruto G; Zina G
Thymus; 1983 Apr; 5(3-4):223-33. PubMed ID: 6224319
[TBL] [Abstract][Full Text] [Related]
15. CD40-stimulated B lymphocytes pulsed with tumor antigens are effective antigen-presenting cells that can generate specific T cells.
Lapointe R; Bellemare-Pelletier A; Housseau F; Thibodeau J; Hwu P
Cancer Res; 2003 Jun; 63(11):2836-43. PubMed ID: 12782589
[TBL] [Abstract][Full Text] [Related]
16. T and B lymphocytes of the regional lymph nodes in patients with carcinoma of uterine cervix.
Ilyin NV; Dexter LI; Bochman YaV
Neoplasma; 1979; 26(4):423-7. PubMed ID: 392325
[TBL] [Abstract][Full Text] [Related]
17. Comparative study on the effects of recombinant alpha-2 interferon on immune function in patients with disseminated melanoma.
Hersey P; Coates A; Rallings M; Hall C; MacDonald M; Spurling A; Edwards A; McCarthy WH; Milton GW
J Biol Response Mod; 1986 Jun; 5(3):236-49. PubMed ID: 3487622
[TBL] [Abstract][Full Text] [Related]
18. Enumeration of T and B lymphocytes in whole peripheral blood: absence of a null cell population.
Pepys EO; Tennent GA; Pepys MB
Clin Exp Immunol; 1981 Oct; 46(1):229-34. PubMed ID: 7039881
[TBL] [Abstract][Full Text] [Related]
19. [Immunophenotype of lymphocytes of patients with malignant melanoma and its dynamics during immunotherapy with interleukin-2].
Kadagidze ZG; Iavorskiĭ VV; Baryshnikov AIu; Solov'eva EA; Savel'eva EV; Cheremushkin EA; Korotkova OV
Vopr Onkol; 1991; 37(5):544-9. PubMed ID: 1767507
[TBL] [Abstract][Full Text] [Related]
20. Detection of specific immunoreactivity by LAI assay in patients with malignant melanoma of uveal tissue.
Kalafut F; Cernák A; Pham Manh Hung
Neoplasma; 1979; 26(3):299-305. PubMed ID: 394010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
